Table 1 Clinicopathological characteristics of breast carcinoma patients and tumors
Clinical criteria | Frequency, n (%) | Clinical criteria | Frequency, n (%) |
|---|---|---|---|
Age of diagnosis | Recurrence | ||
≤40 | 4 (6.9) | No | 56 (96.6) |
≥40 | 54 (93.1) | Yes | 2 (3.4) |
Ethnicity | Estrogen Receptor | ||
Malay | 54 (93.1) | Positive | 32 (55.2) |
Chinese | 4 (6.9) | Negative | 26 (44.8) |
Tumor Size (mm) | Progesteron Receptor | ||
<30 | 11 (19.0) | Positive | 28 (48.3) |
30 ≤ × < 60 | 27 (46.6) | Negative | 30 (51.7) |
>60 | 17 (29.3) | ||
No data | 3 (5.1) | ||
Tumor Grading | Lymph nodes involvement | ||
Grade I | 10 (17.2) | 1 | 19 (32.8) |
Grade II | 27 (46.6) | 2-4 | 6 (10.3) |
Grade III | 16 (27.6) | >4 | 16 (27.6) |
Not determined | 5 (8.6) | Not involved | 17 (29.3) |
Distant Metastasis | Lymphovascular Invasion (H&E) | ||
Yes | 15 (25.9) | Positive | 26 (44.8) |
No | 37 (63.8) | Negative | 28 (48.3) |
Not determined | 6 (10.3) | Not determined | 4 (6.9) |
Mastectomy | |||
Full | 10 (17.2) | ||
Partial | 48 (82.8) | ||